| Ytd | -34.76% | |
| 1y | 67.03% |
| Open | 3.02 | Prev Close | 3.01 | Low | 2.99 | High | 3.12 | Mkt Cap | 10.19M |
| Vol | 77.96K | Avg Vol | 101.59K | EPS | -4.52 | P/E | -0.67 | Forward P/E | N/A |
| Beta | 1.86 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.35 | 200-d Avg | 3.37 | 1yr Est | 0.00 |
New York, New York--(Newsfile Corp. - April 29, 2026) - GridAI Technologies Corp. (NASDAQ: GRDX), an
Boca Raton, Florida--(Newsfile Corp. - April 28, 2026) - GridAI Technologies Corp. (NASDAQ: GRDX) (t
GridAI software platform to orchestrate power across Amp Z's Planned Portfolio of 5GW+ of AI Data Ce
BOCA RATON, FL / ACCESS Newswire / February 4, 2026 / GridAI Technologies Corp. (Nasdaq:GRDX), a tec
BOCA RATON, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- via IBN – GridAI Technologies Corp. (Nasdaq: GRD
BOCA RATON, FL / ACCESS Newswire / January 14, 2026 / For decades, managing the electric grid was la
BOCA RATON, FL / ACCESS Newswire / January 13, 2026 / Infrastructure narratives are easy to tell. Ex
BOCA RATON, FL / ACCESS Newswire / January 12, 2026 / Grid intelligence only matters if it changes c
BOCA RATON, FL / ACCESS Newswire / December 4, 2025 / GridAI Technologies Corp (NASDAQ:GRDX) ("GridA
BOCA RATON, FL / ACCESS Newswire / November 28, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) (the
BOCA RATON, FLORIDA / ACCESS Newswire / November 19, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO)
Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects ann
Integration boosts Grid AI's deployment capacity as AI data-center power demand approaches 50 GW, gr
BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics (NASDAQ:ENTO ) has just ma
BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics, Inc. ("Entero" or the "Co
BOCA RATON, FL / ACCESS Newswire / October 16, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("ENTO
BOCA RATON, FL / ACCESS Newswire / October 14, 2025 / Entero Therapeutics (NASDAQ: ENTO ) has reinve
BOCA RATON, FL / ACCESS Newswire / October 14, 2025 / Entero Therapeutics (NASDAQ:ENTO ) didn't tipt